Sustained Remission in Tumor Necrosis Factor Inhibitor-treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study.

Jon Thorkell Einarsson; Pierre Geborek; Tore Saxne; Meliha C Kapetanovic

doi:10.3899/jrheum.131502

Sustained Remission in Tumor Necrosis Factor Inhibitor-treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study.

Jon Thorkell Einarsson, Pierre Geborek, Tore Saxne, Meliha C Kapetanovic

Rheumatology

Research output: Contribution to journal › Article › peer-review

Abstract

To study frequency, possible baseline predictors, timing, and duration of sustained remission [SR; defined as 28-joint Disease Activity Score (DAS28) < 2.6 for at least 6 mos] in patients with established rheumatoid arthritis (RA) treated with different tumor necrosis factor (TNF) inhibitors [etanercept (ETN), infliximab (IFX), adalimumab (ADA)]. In addition, the aim was to compare (head-to-head) the effectiveness of individual drugs in patients receiving their first anti-TNF treatment.

Original language	English
Pages (from-to)	741-748
Journal	Journal of Rheumatology
Volume	42
Issue number	5
DOIs	https://doi.org/10.3899/jrheum.131502
Publication status	Published - 2015

Subject classification (UKÄ)

Rheumatology and Autoimmunity

Access to Document

10.3899/jrheum.131502

http://www.ncbi.nlm.nih.gov/pubmed/25684762?dopt=Abstract

1 Doctoral Thesis (compilation)

Impact of Drug Induced Remission in Rheumatoid Arthritis
Einarsson, J. T., 2018, Lund: Lund University: Faculty of Medicine. 103 p.
Research output: Thesis › Doctoral Thesis (compilation)

Open Access
File

Cite this

@article{d4242dd415c94bc5ab04f99de6fdfb4d,

title = "Sustained Remission in Tumor Necrosis Factor Inhibitor-treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study.",

abstract = "To study frequency, possible baseline predictors, timing, and duration of sustained remission [SR; defined as 28-joint Disease Activity Score (DAS28) < 2.6 for at least 6 mos] in patients with established rheumatoid arthritis (RA) treated with different tumor necrosis factor (TNF) inhibitors [etanercept (ETN), infliximab (IFX), adalimumab (ADA)]. In addition, the aim was to compare (head-to-head) the effectiveness of individual drugs in patients receiving their first anti-TNF treatment.",

author = "Einarsson, {Jon Thorkell} and Pierre Geborek and Tore Saxne and {C Kapetanovic}, Meliha",

year = "2015",

doi = "10.3899/jrheum.131502",

language = "English",

volume = "42",

pages = "741--748",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology Publishing Company Limited",

number = "5",

}

TY - JOUR

T1 - Sustained Remission in Tumor Necrosis Factor Inhibitor-treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study.

AU - Einarsson, Jon Thorkell

AU - Geborek, Pierre

AU - Saxne, Tore

AU - C Kapetanovic, Meliha

PY - 2015

Y1 - 2015

N2 - To study frequency, possible baseline predictors, timing, and duration of sustained remission [SR; defined as 28-joint Disease Activity Score (DAS28) < 2.6 for at least 6 mos] in patients with established rheumatoid arthritis (RA) treated with different tumor necrosis factor (TNF) inhibitors [etanercept (ETN), infliximab (IFX), adalimumab (ADA)]. In addition, the aim was to compare (head-to-head) the effectiveness of individual drugs in patients receiving their first anti-TNF treatment.

AB - To study frequency, possible baseline predictors, timing, and duration of sustained remission [SR; defined as 28-joint Disease Activity Score (DAS28) < 2.6 for at least 6 mos] in patients with established rheumatoid arthritis (RA) treated with different tumor necrosis factor (TNF) inhibitors [etanercept (ETN), infliximab (IFX), adalimumab (ADA)]. In addition, the aim was to compare (head-to-head) the effectiveness of individual drugs in patients receiving their first anti-TNF treatment.

U2 - 10.3899/jrheum.131502

DO - 10.3899/jrheum.131502

M3 - Article

C2 - 25684762

SN - 0315-162X

VL - 42

SP - 741

EP - 748

JO - Journal of Rheumatology

JF - Journal of Rheumatology

IS - 5

ER -

Sustained Remission in Tumor Necrosis Factor Inhibitor-treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study.

Abstract

Subject classification (UKÄ)

Access to Document

Fingerprint

Research output

Impact of Drug Induced Remission in Rheumatoid Arthritis

Cite this